Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
55
TXRH Quote, Financials, Valuation and Earnings
Last price:
$181.36
Seasonality move
:
6.06%
Day range:
$180.76 - $184.65
52-week range:
$115.48 - $206.04
Dividend yield:
1.35%
P/E ratio:
31.14x
P/S ratio:
2.38x
P/B ratio:
9.24x
Volume:
1.5M
Avg. volume:
674K
1-year change:
53.23%
Market cap:
$12.1B
Revenue:
$4.6B
EPS (TTM):
$5.82
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.4B | $3.5B | $4B | $4.6B | |
| Revenue Growth (YoY) | 12.16% | -12.99% | 44.44% | 15.91% | 15.36% | |
| Cost of Revenues | $2.3B | $2.1B | $2.9B | $3.4B | $3.9B | |
| Gross Profit | $496.2M | $283.6M | $606.5M | $653.6M | $735.1M | |
| Gross Profit Margin | 18% | 11.83% | 17.51% | 16.28% | 15.87% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $149.4M | $119.5M | $157.5M | $172.7M | $198.4M | |
| Other Inc / (Exp) | $1.3M | -$2.8M | -$1.4M | -$361K | $1.1M | |
| Operating Expenses | $285.1M | $257.5M | $308.6M | $331.8M | $380.8M | |
| Operating Income | $211.1M | $26.1M | $297.9M | $321.8M | $354.3M | |
| Net Interest Expenses | -- | $4.1M | $3.7M | $124K | -- | |
| EBT. Incl. Unusual Items | $213.9M | $19.3M | $292.9M | $321.3M | $358.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $32.4M | -$15.7M | $39.6M | $43.7M | $44.6M | |
| Net Income to Company | $181.5M | $34.9M | $253.3M | $277.6M | $313.7M | |
| Minority Interest in Earnings | -$7.1M | -$3.7M | -$8M | -$7.8M | -$8.8M | |
| Net Income to Common Excl Extra Items | $174.5M | $31.3M | $245.3M | $269.8M | $304.9M | |
| Basic EPS (Cont. Ops) | $2.47 | $0.45 | $3.52 | $3.99 | $4.56 | |
| Diluted EPS (Cont. Ops) | $2.46 | $0.45 | $3.50 | $3.97 | $4.54 | |
| Weighted Average Basic Share | $70.5M | $69.4M | $69.7M | $67.6M | $66.9M | |
| Weighted Average Diluted Share | $70.9M | $69.9M | $70.1M | $67.9M | $67.1M | |
| EBITDA | $326.7M | $141.2M | $424.7M | $459M | $507.5M | |
| EBIT | $211.1M | $23.3M | $297.9M | $321.8M | $354.3M | |
| Revenue (Reported) | $2.8B | $2.4B | $3.5B | $4B | $4.6B | |
| Operating Income (Reported) | $211.1M | $26.1M | $297.9M | $321.8M | $354.3M | |
| Operating Income (Adjusted) | $211.1M | $23.3M | $297.9M | $321.8M | $354.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $631.2M | $868.9M | $993.3M | $1.1B | $1.3B | |
| Revenue Growth (YoY) | -2.97% | 37.67% | 14.31% | 12.93% | 13.48% | |
| Cost of Revenues | $535.3M | $727.6M | $835M | $952.4M | $1.1B | |
| Gross Profit | $95.9M | $141.3M | $158.3M | $169.4M | $209.8M | |
| Gross Profit Margin | 15.19% | 16.26% | 15.94% | 15.1% | 16.48% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $26M | $41.2M | $42.8M | $47.7M | $55.1M | |
| Other Inc / (Exp) | -$715K | $237K | -$582K | $141K | -$609K | |
| Operating Expenses | $60.2M | $79.6M | $82.2M | $95.5M | $106.9M | |
| Operating Income | $35.7M | $61.7M | $76.1M | $73.9M | $102.9M | |
| Net Interest Expenses | $1.5M | $604K | $85K | -- | -- | |
| EBT. Incl. Unusual Items | $33.5M | $61.4M | $75.4M | $74.5M | $104.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.1M | $7.1M | $11.4M | $8.9M | $17.4M | |
| Net Income to Company | $30.4M | $54.2M | $64M | $65.6M | $86.8M | |
| Minority Interest in Earnings | -$1.2M | -$1.6M | -$1.6M | -$1.8M | -$2.4M | |
| Net Income to Common Excl Extra Items | $29.2M | $52.6M | $62.3M | $63.8M | $84.4M | |
| Basic EPS (Cont. Ops) | $0.42 | $0.75 | $0.93 | $0.96 | $1.27 | |
| Diluted EPS (Cont. Ops) | $0.42 | $0.75 | $0.93 | $0.95 | $1.26 | |
| Weighted Average Basic Share | $69.4M | $69.8M | $66.9M | $66.8M | $66.7M | |
| Weighted Average Diluted Share | $69.9M | $70.1M | $67.2M | $67M | $66.9M | |
| EBITDA | $64.3M | $93.6M | $109.2M | $113M | $147.4M | |
| EBIT | $35M | $62M | $75.5M | $73.9M | $102.9M | |
| Revenue (Reported) | $631.2M | $868.9M | $993.3M | $1.1B | $1.3B | |
| Operating Income (Reported) | $35.7M | $61.7M | $76.1M | $73.9M | $102.9M | |
| Operating Income (Adjusted) | $35M | $62M | $75.5M | $73.9M | $102.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $3.2B | $3.9B | $4.5B | $5.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.2B | $2.7B | $3.3B | $3.8B | $4.2B | |
| Gross Profit | $323.2M | $548.2M | $648.6M | $703.7M | $879.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $126.7M | $145.8M | $175M | $189M | $215.7M | |
| Other Inc / (Exp) | $103K | -$1.6M | -$5.9M | -$5.5M | -$6.5M | |
| Operating Expenses | $266.8M | $293.5M | $326.4M | $357.8M | $409.9M | |
| Operating Income | $56.4M | $254.7M | $322.2M | $345.9M | $469.2M | |
| Net Interest Expenses | $2.6M | $4.5M | $1.5M | -- | -- | |
| EBT. Incl. Unusual Items | $53.9M | $248.6M | $314.8M | $343.9M | $467.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$4.9M | $29.4M | $44.3M | $43.5M | $67.1M | |
| Net Income to Company | $58.9M | $219.2M | $270.6M | $300.4M | $400.9M | |
| Minority Interest in Earnings | -$4.5M | -$7.5M | -$7.6M | -$8.1M | -$10.7M | |
| Net Income to Common Excl Extra Items | $54.4M | $211.8M | $263M | $292.3M | $390.2M | |
| Basic EPS (Cont. Ops) | $0.78 | $3.03 | $3.85 | $4.37 | $5.84 | |
| Diluted EPS (Cont. Ops) | $0.78 | $3.02 | $3.84 | $4.34 | $5.82 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $173.4M | $377.7M | $457.3M | $493.6M | $638.6M | |
| EBIT | $55M | $253.1M | $322.9M | $345.4M | $469.2M | |
| Revenue (Reported) | $2.5B | $3.2B | $3.9B | $4.5B | $5.1B | |
| Operating Income (Reported) | $56.4M | $254.7M | $322.2M | $345.9M | $469.2M | |
| Operating Income (Adjusted) | $55M | $253.1M | $322.9M | $345.4M | $469.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $2.6B | $3B | $3.5B | $3.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.6B | $2.1B | $2.5B | $2.9B | $3.2B | |
| Gross Profit | $194.6M | $459.2M | $501.3M | $551.4M | $695.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $88.5M | $114.8M | $132.3M | $148.6M | $165.9M | |
| Other Inc / (Exp) | -$1.5M | -$262K | -$4.8M | -$4.6M | -$6.6M | |
| Operating Expenses | $190.3M | $226.3M | $244.1M | $275.4M | $310.2M | |
| Operating Income | $4.3M | $232.9M | $257.2M | $276M | $385.3M | |
| Net Interest Expenses | $2.6M | $3M | $877K | -- | -- | |
| EBT. Incl. Unusual Items | $250K | $229.6M | $251.5M | $274.1M | $383.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$14M | $31M | $35.7M | $35.5M | $57.9M | |
| Net Income to Company | $14.2M | $198.6M | $215.8M | $238.7M | $325.8M | |
| Minority Interest in Earnings | -$2.5M | -$6.3M | -$5.9M | -$6.2M | -$8.1M | |
| Net Income to Common Excl Extra Items | $11.7M | $192.2M | $209.9M | $232.4M | $317.8M | |
| Basic EPS (Cont. Ops) | $0.17 | $2.75 | $3.09 | $3.48 | $4.76 | |
| Diluted EPS (Cont. Ops) | $0.17 | $2.74 | $3.08 | $3.45 | $4.74 | |
| Weighted Average Basic Share | $208.2M | $209.2M | $203.6M | $200.8M | $200.3M | |
| Weighted Average Diluted Share | $209.1M | $210.4M | $204.4M | $201.5M | $201.1M | |
| EBITDA | $90.3M | $326.8M | $359.4M | $388.8M | $514.2M | |
| EBIT | $2.9M | $232.6M | $257.6M | $276M | $385.3M | |
| Revenue (Reported) | $1.8B | $2.6B | $3B | $3.5B | $3.9B | |
| Operating Income (Reported) | $4.3M | $232.9M | $257.2M | $276M | $385.3M | |
| Operating Income (Adjusted) | $2.9M | $232.6M | $257.6M | $276M | $385.3M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $107.9M | $363.2M | $335.6M | $173.9M | $104.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $99.3M | $98.4M | $161.4M | $150.3M | $175.5M | |
| Inventory | $20.3M | $22.4M | $31.6M | $38M | $38.3M | |
| Prepaid Expenses | $20.4M | $26.7M | $34.9M | $5.1M | $3.3M | |
| Other Current Assets | -- | -- | -- | $29.6M | $35.2M | |
| Total Current Assets | $247.9M | $510.7M | $563.5M | $396.8M | $356.5M | |
| Property Plant And Equipment | $1.6B | $1.6B | $1.7B | $1.9B | $2.2B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $124.7M | $127M | $127M | $148.7M | $169.7M | |
| Other Intangibles | $1.2M | $2.3M | $1.5M | $12M | $12.9M | |
| Other Long-Term Assets | $53.3M | $66M | $79.1M | $73.9M | $95M | |
| Total Assets | $2B | $2.3B | $2.5B | $2.5B | $2.8B | |
| Accounts Payable | $61.7M | $67M | $95.2M | $105.6M | $131.6M | |
| Accrued Expenses | $98.6M | $109.6M | $150.8M | $149.9M | $169.6M | |
| Current Portion Of Long-Term Debt | -- | $50M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $17.3M | $19.3M | $22M | $25.5M | $27.4M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $417.2M | $506.3M | $602.1M | $652M | $745.4M | |
| Long-Term Debt | -- | $190M | $100M | $50M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1B | $1.4B | $1.4B | $1.5B | $1.6B | |
| Common Stock | $69K | $70K | $69K | $67K | $67K | |
| Other Common Equity Adj | -$225K | -$106K | -- | -- | -- | |
| Common Equity | $916M | $927.5M | $1.1B | $1B | $1.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $15.2M | $15.5M | $15.4M | $15M | $15.8M | |
| Total Equity | $931.2M | $943.1M | $1.1B | $1B | $1.2B | |
| Total Liabilities and Equity | $2B | $2.3B | $2.5B | $2.5B | $2.8B | |
| Cash and Short Terms | $107.9M | $363.2M | $335.6M | $173.9M | $104.2M | |
| Total Debt | -- | $240M | $100M | $50M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $328.6M | $436.6M | $185.3M | $69.3M | $189.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $32M | $52.3M | $37.8M | $49M | $52.3M | |
| Inventory | $19.9M | $27.8M | $32.9M | $36.6M | $39.8M | |
| Prepaid Expenses | $19M | $21.2M | $21.4M | $2.8M | -- | |
| Other Current Assets | -- | -- | -- | $23.8M | $26M | |
| Total Current Assets | $399.5M | $537.9M | $277.4M | $181.5M | $307.4M | |
| Property Plant And Equipment | $1.6B | $1.7B | $1.9B | $2.1B | $2.3B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $124.7M | $127M | $148.7M | $169.7M | $169.7M | |
| Other Intangibles | $890K | $1.7M | $6.3M | $4.2M | $1.7M | |
| Other Long-Term Assets | $59.4M | $77.8M | $68.7M | $86.7M | $112.8M | |
| Total Assets | $2.2B | $2.4B | $2.4B | $2.5B | $2.9B | |
| Accounts Payable | $65.8M | $80.4M | $98.7M | $126.2M | $130.9M | |
| Accrued Expenses | $86M | $142.7M | $85.1M | $163.6M | $189.7M | |
| Current Portion Of Long-Term Debt | $50M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $18.6M | $21.3M | $25M | $27.2M | $28.5M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $396.4M | $443.9M | $515.7M | $561.4M | $627.6M | |
| Long-Term Debt | $190M | $190M | $75M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.4B | $1.4B | $1.4B | $1.6B | |
| Common Stock | $69K | $70K | $67K | $67K | $67K | |
| Other Common Equity Adj | -$178K | -$96K | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $15.6M | $15.4M | $15.1M | $15.2M | $15M | |
| Total Equity | $918.5M | $1.1B | $992.6M | $1.1B | $1.3B | |
| Total Liabilities and Equity | $2.2B | $2.4B | $2.4B | $2.5B | $2.9B | |
| Cash and Short Terms | $328.6M | $436.6M | $185.3M | $69.3M | $189.2M | |
| Total Debt | $240M | $190M | $75M | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $181.5M | $34.9M | $253.3M | $277.6M | $313.7M | |
| Depreciation & Amoritzation | $115.5M | $117.9M | $126.8M | $137.2M | $153.2M | |
| Stock-Based Compensation | $35.5M | $29.4M | $38.1M | $36.7M | $34.2M | |
| Change in Accounts Receivable | -$5.8M | $1.1M | -$62.4M | $11.1M | -$24.4M | |
| Change in Inventories | -$1.4M | -$2M | -$9.2M | -$6.1M | $105K | |
| Cash From Operations | $374.3M | $230.4M | $468.8M | $511.7M | $565M | |
| Capital Expenditures | $214.3M | $154.4M | $200.7M | $246.1M | $347M | |
| Cash Acquisitions | -$1.5M | -$10.6M | -- | -$32.8M | -$38.5M | |
| Cash From Investing | -$214.8M | -$161.1M | -$195.1M | -$263.7M | -$367.2M | |
| Dividends Paid (Ex Special Dividend) | -$102.4M | -$25M | -$83.7M | -$124.1M | -$147.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $240M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$140M | -$50M | -$50M | |
| Repurchase of Common Stock | -$152.3M | -$25.1M | -$69.3M | -$226.4M | -$62.7M | |
| Other Financing Activities | -$7.1M | -$3.9M | -$8.9M | -$9.5M | -$8M | |
| Cash From Financing | -$261.7M | $185.9M | -$301.2M | -$409.8M | -$267.4M | |
| Beginning Cash (CF) | $210.1M | $107.9M | $363.2M | $335.6M | $173.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$102.2M | $255.3M | -$27.5M | -$161.8M | -$69.6M | |
| Ending Cash (CF) | $107.9M | $363.2M | $335.6M | $173.9M | $104.2M | |
| Levered Free Cash Flow | $160M | $76M | $268.1M | $265.6M | $218M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $30.4M | $54.2M | $64M | $65.6M | $86.8M | |
| Depreciation & Amoritzation | $29.4M | $31.6M | $33.7M | $39.1M | $44.5M | |
| Stock-Based Compensation | $7.6M | $11M | $9.6M | $8.5M | $14.8M | |
| Change in Accounts Receivable | -$1.7M | -$3.7M | $7.6M | $11.6M | $16.3M | |
| Change in Inventories | $3.2M | -$2.2M | -$1.1M | $1.5M | $1.4M | |
| Cash From Operations | $84.2M | $51.9M | $96.4M | $102.5M | $138.7M | |
| Capital Expenditures | $35.7M | $53.9M | $65.6M | $89.3M | $91.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$35.7M | -$51.6M | -$56.5M | -$87.5M | -$91.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -$27.9M | -$30.8M | -$36.7M | -$40.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$2.3M | -$17.3M | -$2.4M | -$14.5M | -$12.7M | |
| Other Financing Activities | -$119K | -$2M | -$1.7M | -$1.9M | -$2.5M | |
| Cash From Financing | -$2.4M | -$47.1M | -$35M | -$53M | -$55.9M | |
| Beginning Cash (CF) | $282.5M | $483.4M | $180.4M | $107.3M | $197.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $46.1M | -$46.9M | $4.9M | -$38M | -$8.2M | |
| Ending Cash (CF) | $328.6M | $436.6M | $185.3M | $69.3M | $189.2M | |
| Levered Free Cash Flow | $48.5M | -$2.1M | $30.7M | $13.2M | $47.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $58.9M | $219.2M | $270.6M | $300.4M | $400.9M | |
| Depreciation & Amoritzation | $118.4M | $124.6M | $134.4M | $148.2M | $169.4M | |
| Stock-Based Compensation | $32.6M | $38.2M | $35.5M | $33.7M | $42.1M | |
| Change in Accounts Receivable | $2.5M | -$19.8M | $14.8M | -$10.4M | -$3.3M | |
| Change in Inventories | -$2.7M | -$7.8M | -$4.8M | -$3.3M | -$3.3M | |
| Cash From Operations | $278.3M | $433.1M | $515.2M | $507.4M | $690.3M | |
| Capital Expenditures | $186.9M | $175.9M | $235.9M | $315.8M | $349.7M | |
| Cash Acquisitions | -- | -- | -$32.8M | -$38.5M | -$5K | |
| Cash From Investing | -$185.6M | -$179.2M | -$257.3M | -$341.6M | -$330.9M | |
| Dividends Paid (Ex Special Dividend) | -$66.7M | -$55.8M | -$121.1M | -$141.2M | -$159M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $240M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$115M | -$75M | -- | |
| Repurchase of Common Stock | -$32.6M | -$32.5M | -$263.7M | -$58.3M | -$65.6M | |
| Other Financing Activities | -$4.2M | -$8.3M | -$9.3M | -$8M | -$15.3M | |
| Cash From Financing | $136.3M | -$146M | -$509.1M | -$281.8M | -$239.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $229.1M | $107.9M | -$251.2M | -$116M | $119.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $91.4M | $257.2M | $279.3M | $191.6M | $340.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.2M | $198.6M | $215.8M | $238.7M | $325.8M | |
| Depreciation & Amoritzation | $87.4M | $94.1M | $101.8M | $112.8M | $128.9M | |
| Stock-Based Compensation | $22.1M | $30.8M | $28.2M | $25.3M | $33.2M | |
| Change in Accounts Receivable | $67.3M | $46.4M | $123.6M | $102.1M | $123.2M | |
| Change in Inventories | $378K | -$5.4M | -$990K | $1.8M | -$1.5M | |
| Cash From Operations | $146M | $348.7M | $395.1M | $390.7M | $516.1M | |
| Capital Expenditures | $117.5M | $139M | $174.2M | $243.9M | $246.5M | |
| Cash Acquisitions | -- | -- | -$32.8M | -$38.5M | -- | |
| Cash From Investing | -$115.3M | -$133.4M | -$195.6M | -$273.5M | -$237.2M | |
| Dividends Paid (Ex Special Dividend) | -$25M | -$55.8M | -$93.3M | -$110.4M | -$122.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $240M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$50M | -$25M | -$50M | -- | |
| Repurchase of Common Stock | -$22.2M | -$29.5M | -$224M | -$55.8M | -$58.7M | |
| Other Financing Activities | -$2.8M | -$7.2M | -$7.6M | -$6M | -$13.4M | |
| Cash From Financing | $190M | -$141.9M | -$349.8M | -$221.8M | -$193.9M | |
| Beginning Cash (CF) | $621M | $1.3B | $841.8M | $437.3M | $515.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $220.8M | $73.4M | -$150.3M | -$104.5M | $85M | |
| Ending Cash (CF) | $841.7M | $1.4B | $691.4M | $332.8M | $600.1M | |
| Levered Free Cash Flow | $28.5M | $209.7M | $220.9M | $146.8M | $269.6M | |
Get TXRH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TXRH
Sector
P/E ratio
31.14x
16.83x
PEG ratio
0.91x
0.22x
P/B ratio
9.24x
1.45x
Price / LTM sales
2.38x
0.71x
Growth Metrics
TXRH
Sector
Revenue growth
13.48%
0.14%
Earnings growth
32.63%
--
Revenue (5-year growth)
13.51%
3.45%
Earnings forecast
$1.32
$0.30
Profitability
TXRH
Sector
Profitability FY 2023
$735.1M
$503.7M
Return on invested capital
31.98%
5.17%
Return on assets
13.99%
3.13%
Return on equity
31.98%
7.63%
Earnings Date
Last Earnings Date
Oct
24
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Jan
23
Balance Sheet
TXRH
Sector
Total cash
$189.2M
$157.7M
Short term investments
--
$60.7M
Total assets
$2.8B
$1.7B
Long term debt
--
$111.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
